Literature DB >> 17171494

Risk-scoring method for prediction of 30-day postoperative outcome after infrainguinal surgical revascularization for critical lower-limb ischemia: a Finnvasc registry study.

Fausto Biancari1, Juha-Pekka Salenius, Maarit Heikkinen, Michael Luther, Kari Ylönen, Mauri Lepäntalo.   

Abstract

BACKGROUND: The aim of the present study was to develop a risk-scoring method for prediction of immediate postoperative outcome after infrainguinal surgical revascularization for critical limb ischemia.
METHODS: The Finnvasc registry included data on 3,925 infrainguinal surgical revascularization procedures. This database was randomly divided into a derivation and a validation data set of similar sizes.
RESULTS: In the overall series, 30-day postoperative mortality and major amputation rates were 3.1% and 6.3%, respectively. The 30-day postoperative mortality and/or limb-loss rate was 9.2%. Diabetes, coronary artery disease, foot gangrene, and urgent operation were independent predictors of 30-day postoperative mortality and/or major lower-limb amputation. A risk score was developed by assigning 1 point each to the latter risk factors. In the derivation data set, the 30-day postoperative mortality/amputation rates in patients with scores of 0, 1, 2, 3, and 4 were 7.7%, 6.4%, 11.1%, 20.4%, and 27.3%, respectively, (P < 0.0001); mortality rates were 1.3%, 2.3%, 4.1%, 7.7%, and 12.1%, respectively, (P < 0.0001); and major amputation rates were 6.4%, 4.3%, 7.1%, 12.7%, and 18.2%, respectively, (P < 0.0001). In the validation data set, the 30-day postoperative mortality/amputation rates in patients with scores of 0, 1, 2, 3, and 4 were 4.8%, 7.5%, 10.1%, 15.9%, and 22.2%, respectively, (P < 0.0001); mortality rates were 0.7%, 2.3%, 4.2%, 5.5%, and 14.8%, respectively, (P < 0.0001); and major amputation rates were 4.6%, 5.3%, 6.4%, 11.0%, and 14.0%, respectively (P = 0.011).
CONCLUSIONS: This simple risk-scoring method can be useful to stratify the immediate postoperative outcome of patients undergoing infrainguinal surgical revascularization for critical lower-limb ischemia.

Entities:  

Mesh:

Year:  2007        PMID: 17171494     DOI: 10.1007/s00268-006-0242-y

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  13 in total

Review 1.  Second European Consensus Document on chronic critical leg ischemia.

Authors: 
Journal:  Eur J Vasc Surg       Date:  1992-05

2.  National vascular registry in Finland--FINNVASC. FINNVASC Study Group.

Authors:  J P Salenius
Journal:  Ann Chir Gynaecol       Date:  1992

3.  Meta-analysis of popliteal-to-distal vein bypass grafts for critical ischemia.

Authors:  Maximiano Albers; Marcello Romiti; Francisco Cardoso Brochado-Neto; Nelson De Luccia; Carlos Alberto Bragança Pereira
Journal:  J Vasc Surg       Date:  2006-03       Impact factor: 4.268

4.  Limits of infrapopliteal bypass surgery for critical leg ischemia: when not to reconstruct.

Authors:  F Biancari; I Kantonen; A Albäck; S Mätzke; M Luther; M Lepäntalo
Journal:  World J Surg       Date:  2000-06       Impact factor: 3.352

5.  Graft patency and clinical outcome of femorodistal arterial reconstruction in diabetic and non-diabetic patients: results of a multicentre comparative analysis.

Authors:  K D Wölfle; H Bruijnen; H Loeprecht; G Rümenapf; H Schweiger; K Grabitz; W Sandmann; L Lauterjung; J Largiader; H Erasmi; P M Kasprzak; D Raithel; J R Allenberg; A Lauber; G M Berlakovich; G Kretschmer; W Hepp; H M Becker; A Schulz
Journal:  Eur J Vasc Endovasc Surg       Date:  2003-03       Impact factor: 7.069

6.  Assessment of smoking status in patients with peripheral arterial disease.

Authors:  Simon D Hobbs; Antonius B M Wilmink; Donald J Adam; Andrew W Bradbury
Journal:  J Vasc Surg       Date:  2005-03       Impact factor: 4.268

7.  Angiographic runoff score as a predictor of outcome following femorocrural bypass surgery.

Authors:  F Biancari; A Albäck; L Ihlberg; I Kantonen; M Luther; M Lepäntalo
Journal:  Eur J Vasc Endovasc Surg       Date:  1999-06       Impact factor: 7.069

8.  Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery.

Authors:  Michael S Conte; Dennis F Bandyk; Alexander W Clowes; Gregory L Moneta; Lynn Seely; Todd J Lorenz; Hamid Namini; Allen D Hamdan; Sean P Roddy; Michael Belkin; Scott A Berceli; Richard J DeMasi; Russell H Samson; Scott S Berman
Journal:  J Vasc Surg       Date:  2006-04       Impact factor: 4.268

9.  Lower limb amputations in Southern Finland in 2000 and trends up to 2001.

Authors:  E Eskelinen; M Lepäntalo; E-M Hietala; H Sell; L Kauppila; I Mäenpää; J Pitkänen; P Salminen-Peltola; S Leutola; A Eskelinen; A Kivioja; E Tukiainen; A Lukinmaa; P Brasken; M Railo
Journal:  Eur J Vasc Endovasc Surg       Date:  2004-02       Impact factor: 7.069

10.  Infrapopliteal bypass reduces amputation incidence in elderly patients: a population-based study.

Authors:  E Eskelinen; M Luther; A Eskelinen; M Lepäntalo
Journal:  Eur J Vasc Endovasc Surg       Date:  2003-07       Impact factor: 7.069

View more
  18 in total

1.  Early-phase wound healing and long-term outcomes of a selective endovascular-first approach for treating Rutherford 5 critical limb ischemia with infrainguinal lesions.

Authors:  Kentaro Inoue; Toshihiro Onohara; Keita Mikasa; Tadashi Furuyama
Journal:  Surg Today       Date:  2016-04-18       Impact factor: 2.549

2.  High hemoglobin A1c associated with increased adverse limb events in peripheral arterial disease patients undergoing revascularization.

Authors:  Shipra Arya; Zachary O Binney; Anjali Khakharia; Chandler A Long; Luke P Brewster; Peter W Wilson; William D Jordan; Yazan Duwayri
Journal:  J Vasc Surg       Date:  2017-08-31       Impact factor: 4.268

3.  The role of chronic kidney disease as a predictor of outcome after revascularisation of the ulcerated diabetic foot.

Authors:  M Venermo; F Biancari; E Arvela; M Korhonen; M Söderström; K Halmesmäki; A Albäck; M Lepäntalo
Journal:  Diabetologia       Date:  2011-08-16       Impact factor: 10.122

4.  Matrix metalloproteinases and risk stratification in patients undergoing surgical revascularisation for critical limb ischaemia.

Authors:  Giovanni De Caridi; Mafalda Massara; Francesco Spinelli; Antonio David; Sebastiano Gangemi; Francesco Fugetto; Raffaele Grande; Lucia Butrico; Roberta Stefanelli; Manuela Colosimo; Stefano de Franciscis; Raffaele Serra
Journal:  Int Wound J       Date:  2015-05-27       Impact factor: 3.315

5.  Critical limb ischemia.

Authors:  Andres Schanzer; Michael S Conte
Journal:  Curr Treat Options Cardiovasc Med       Date:  2010-04-14

6.  Determinants of survival and major amputation after peripheral endovascular intervention for critical limb ischemia.

Authors:  Luke Vierthaler; Peter W Callas; Philip P Goodney; Andres Schanzer; Virenda I Patel; Jack Cronenwett; Daniel J Bertges
Journal:  J Vasc Surg       Date:  2015-07-26       Impact factor: 4.268

7.  Long-term outcome after isolated endarterectomy of the femoral bifurcation.

Authors:  Aristotelis Kechagias; Kari Ylönen; Fausto Biancari
Journal:  World J Surg       Date:  2008-01       Impact factor: 3.352

8.  A comparative evaluation of risk-adjustment models for benchmarking amputation-free survival after lower extremity bypass.

Authors:  Jessica P Simons; Philip P Goodney; Julie Flahive; Andrew W Hoel; John W Hallett; Larry W Kraiss; Andres Schanzer
Journal:  J Vasc Surg       Date:  2015-11-18       Impact factor: 4.268

9.  The role of amputation as an outcome measure in cellular therapy for critical limb ischemia: implications for clinical trial design.

Authors:  Eric Benoit; Thomas F O'Donnell; Mark D Iafrati; Enrico Asher; Dennis F Bandyk; John W Hallett; Alan B Lumsden; Gregory J Pearl; Sean P Roddy; Krishnaswami Vijayaraghavan; Amit N Patel
Journal:  J Transl Med       Date:  2011-09-27       Impact factor: 5.531

10.  Risk Stratification for 2-Year Mortality in Patients with Chronic Limb-Threatening Ischemia Undergoing Endovascular Therapy.

Authors:  Yosuke Hata; Osamu Iida; Mitsutoshi Asai; Masaharu Masuda; Shin Okamoto; Takayuki Ishihara; Kiyonori Nanto; Takashi Kanda; Takuya Tsujumura; Shota Okuno; Yasuhiro Matsuda; Mitsuyoshi Takahara; Toshiaki Mano
Journal:  J Atheroscler Thromb       Date:  2020-07-23       Impact factor: 4.928

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.